Tech Coast Angels

Tech Coast Angels is the largest angel investor group in the United States, possessing more than 300 members in five networks in Los Angeles, Orange County, San Diego, Central Coast, and the Inland Empire. Its members provide funding and guidance to more early-stage, high-growth companies in Southern California than any other investment group. Members invest in companies in a wide range of industries, including the life sciences, biotech, IT, services, retail, Internet, financial, software, media, consumer products, and tech startups. TCA as a whole gives companies more than just capital; they also provide counsel, mentoring, and access to an extensive network of potential investors, customers, strategic partners, and management talent. Tech Coast Angels has been ranked by CB Insights to be among the Top 20 Angel Groups in the US; TCA was also ranked as #1 for Network Centrality, meaning we have more connections than anyone! If you are in the game-changing business, we are here to help.

Brian Coryat

Member and Angel Investor

586 past transactions

Nob Hill Therapeutics

Series A in 2024
Nob Hill Therapeutics, Inc. is a Delaware Corporation founded in 2016 and based in Fayetteville, Arkansas. The company specializes in developing and marketing DryNeb, a pioneering dry powder nebulizer designed to treat severe respiratory diseases. This innovative device distinguishes itself from traditional aerosol mist nebulizers by being compact, handheld, and portable, providing a more user-friendly experience. The DryNeb nebulizer utilizes a unique mechanism that disperses medication through mechanical collisions within a dispersion chamber, ensuring consistent delivery independent of the patient's inhalation force. This technology allows for effective pulmonary drug delivery, which is increasingly important for both local and systemic treatments due to its high bioavailability and rapid action. Nob Hill Therapeutics has exclusively licensed this technology from the University of New Mexico, positioning itself to address significant market opportunities in pulmonary drug delivery.

Flyte

Seed Round in 2024
Flyte is a femtech company that specializes in developing solutions to cure bladder leaks. It offers an in-home intravaginal device that both treats stress urinary incontinence and provides biofeedback to help patients strengthen pelvic floor muscles at home.

Giftpack

Seed Round in 2023
Giftpack Inc. is an AI-enabled gifting company that specializes in providing a platform for ordering and delivering gifts globally. Founded in 2017 and headquartered in San Francisco, California, Giftpack simplifies the corporate gifting process by utilizing artificial intelligence to analyze recipients' social media and cultural backgrounds. This technology allows businesses to find perfectly matched gifts for employee recognition, client retention, and sales enablement. In addition to gift selection, Giftpack offers automation for global onboarding and tracking of gift deliveries, ensuring a seamless experience for users. By focusing on personalization and efficiency, Giftpack aims to help individuals and businesses cultivate authentic relationships through thoughtful gifting.

Orna

Angel Round in 2023
Orna is a comprehensive incident response automation platform tailored for small and midsize businesses, focusing on enhancing the detection, response, and prevention of cyberattacks. The platform employs an AI-driven security orchestration and response system to monitor cloud, on-premises, and hybrid assets, ensuring 24/7 surveillance and support. Key functionalities include automated threat detection and triage, as well as incident response through scenario-specific playbooks that guide organizations in managing threats effectively. Orna also facilitates the collection of evidence, vulnerability management, and communication across various business functions, including legal and HR. By incorporating features such as compliance management and team training, Orna aims to minimize both financial and reputational damage from cyber incidents, making it an essential tool for organizations seeking to bolster their cybersecurity posture.

Reglagene

Venture Round in 2023
Reglagene LLC is a therapeutics company based in Tucson, Arizona, founded in 2016. The company specializes in gene expression services and research and development, utilizing DNA quadraplex master switch technology to create precise on and off switches for controlling gene expression. Reglagene focuses on developing therapies for a range of diseases, including cancer, neurodegeneration, and metabolic disorders. A key aspect of its work involves transforming tubulin therapy for brain diseases, with an emphasis on creating effective treatments that can penetrate the blood-brain barrier. The company's portfolio includes innovative therapies aimed at addressing brain inflammation and ocular neovascularization, with the goal of combating diseases linked to changes in gene processing rates.

RealSeq Biosciences

Seed Round in 2023
RealSeq Biosciences’ core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.

Trio Pharmaceuticals

Seed Round in 2023
Trio Pharmaceuticals is a San Diego-based company focused on developing innovative cancer therapeutics. Founded in 2018, it specializes in dual-action drugs designed to combat immunogenic tumors. These therapeutics aim to halt tumor growth while selectively addressing immunosuppression within the tumor environment, distinct from conventional immune checkpoint pathways. By targeting specific antigens on cancer cells and immunosuppressor cells, Trio's drugs enhance tumor immunity, improve treatment efficacy, and reduce toxicity. The company's mission is to address significant unmet medical needs in cancer treatment, ultimately making therapies more accessible and affordable for patients.

Celitech

Seed Round in 2022
Celitech is a premium connectivity platform that provides a secure eSIM solution for global travel companies, enhancing cellular data services in over 160 countries. The platform enables travel-related businesses to create new revenue streams and improve mobile engagement by offering affordable data packages that can significantly reduce roaming costs for travelers. Celitech's technology includes a programmable eSIM API that integrates with various web and mobile applications, allowing businesses to utilize mobile analytics for upselling opportunities. By focusing on both customer connectivity and analytics, Celitech helps travel companies enhance their services and engage effectively with their customers.

DAtAnchor

Seed Round in 2022
Traditional IT controls focus on locking down networks, devices, and people. All of this is done in the name of protecting data. But, once files are moved, shared, or stolen, the data is no longer protected. Even worse, these controls get in the way and frustrate business users to the point they intentionally work around them. Anchor inverts the equation by baking protection into the data, invisible to the business users (like antivirus), so that files are free to travel and security is out of the way. Simply put, wherever the data goes, it is protected. Anchor is a SaaS platform, with an endpoint component, that bakes protection into your files with a unique transparent combination of encryption, continuous multi-factor access controls, and a digital chain of custody. And when you do share or collaborate, Anchor protection stays with your data, even when it leaves your organization. Anchor empowers you to maintain control of your files while collaborating on premise or in the cloud, including forensic logging and revoking access. In under 90 minutes, Anchor is fully deployed and empowers your business users to securely work and collaborate without complicated security products or rules in the way. All without requiring you to change existing IT controls or how your users and applications work today. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.

Arima Genomics

Series B in 2022
Arima Genomics, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative solutions for genome sequencing and structural analysis to advance human health and disease research. The company offers Arima-HiC, a proximity ligation kit that captures the three-dimensional organizational structure of chromatin, allowing researchers to understand long-range genomic interactions. Additionally, Arima Genomics provides the Arima-HiChIP protocol, which combines Hi-C and chromatin immunoprecipitation techniques to identify long-range genomic contacts mediated by specific proteins. These technologies are designed to facilitate various genomic applications, such as identifying promoter-enhancer interactions for gene regulation studies and scaffolding contigs for genome assemblies. Arima Genomics was incorporated in 2015 and aims to support genomics discovery through comprehensive services, including study design consultation, sample and library preparation, bioinformatics analysis, and data interpretation.

Lincode

Venture Round in 2022
Lincode is an AI-driven technology company focused on enhancing quality control in manufacturing through advanced machine vision and defect detection. Specializing in sectors such as automotive, aerospace, and industrial manufacturing, Lincode's patent-pending AI platform employs pre-trained models to tackle complex defect detection challenges while minimizing data requirements. By utilizing on-premise edge AI deployments, the company ensures real-time processing and low latency, thus improving production efficiency without relying on cloud services. Lincode's solutions integrate smoothly with existing machine vision systems, enabling manufacturers to detect subtle flaws—such as porosity in automotive components—while reducing costs and enhancing productivity. The platform allows manufacturers to easily configure quality tolerances for defects and adapt seamlessly to both automated and non-automated inspections, making it a scalable and cost-effective choice for achieving high standards in quality control.

Apsy

Seed Round in 2022
Apsy is a company that has developed an innovative AI-driven mobile and web application builder. This platform allows users to create apps quickly and efficiently, transforming ideas into functional applications in just an hour through a simple conversation with an AI agent. By employing machine programming, Apsy provides tools that largely eliminate traditional constraints of time, quality, and cost associated with app development. This enables businesses to generate tailor-made applications that meet their specific needs without the usual limitations. Apsy's approach represents a significant advancement in the way software is developed, allowing for intelligent and repetitive code generation.

Karma Biotechnologies

Seed Round in 2021
Karma Biotechnologies, Inc. is a Los Angeles-based startup focused on developing therapies for autoimmune diseases, allergies, and food sensitivities. Founded in 2019, the company offers Xavines, a precision immunotherapy platform designed to address the critical need for antigen-specific therapies that target only the rogue immune cells responsible for these conditions. Unlike traditional treatments that rely on general immune suppression, Karma Biotechnologies aims to create tolerogenic immunotherapies that promote antigen-specific immune tolerance in vivo. By leveraging its expertise in immunology and lipid nanoparticle engineering, the company seeks to provide innovative solutions that enhance the treatment landscape for autoimmune diseases and related disorders.

Single Pass

Seed Round in 2021
Single Pass is a developer of a disposable bipolar electrocautery device that can cauterize deep tissue through a guide needle.

ChargeNet Stations

Seed Round in 2021
ChargeNet Stations specializes in renewable energy infrastructure, focusing on providing electric vehicle (EV) charging solutions for quick-serve restaurants (QSR). The company's platform enhances the customer experience by allowing patrons to enjoy meals while simultaneously charging their electric vehicles. This dual offering not only meets the growing demand for EV charging but also helps QSR businesses reduce operating costs. By integrating fast charging capabilities with renewable energy, ChargeNet Stations supports the transition to sustainable energy and facilitates the adoption of electric vehicles in the dining sector.

Strategikon Pharma

Series A in 2021
Strategikon Pharma, Inc. specializes in developing software that optimizes the outsourcing processes between sponsors and providers in the pharmaceutical industry. Its flagship product, Clinical Maestro, is a unique platform designed for the comprehensive management of clinical business operations, particularly in planning, outsourcing, and budgeting clinical trials. By facilitating an integrated virtual environment, Clinical Maestro enables biopharmaceutical companies to efficiently manage complex relationships with numerous global service providers who often operate with varying processes and reporting structures. The software replaces traditional, labor-intensive methods—primarily reliant on Excel—leading to significant cost savings and enhanced operational efficiency. Case studies with major pharmaceutical firms highlight the platform's effectiveness, achieving over 80% savings compared to manual processes and over 95% accuracy in predicting clinical study budgets. Founded in 2016 and headquartered in San Rafael, California, Strategikon Pharma also offers consulting services to support new clinical business operations.

Iridia

Series B in 2021
Iridia, Inc. is a nanotechnology company based in Carlsbad, California, that specializes in innovative data storage solutions utilizing DNA. Founded in 2016, the company has developed a groundbreaking technology that allows for the reading and writing of data in DNA, leveraging semiconductor fabrication and proprietary enzymology. By integrating DNA polymer synthesis technology with electronic nano-switches, Iridia offers a highly parallel format capable of storing data at exceptionally high densities. This advancement not only reduces the infrastructure requirements for data storage but also addresses environmental concerns associated with traditional storage methods. Iridia aims to provide an affordable and efficient means for businesses to manage large volumes of data sustainably.

MEALLOGIX

Seed Round in 2021
Meallogix is a leading technology provider for the meal prep sector, offering an all-in-one software solution designed to automate and optimize business processes for meal prep operators. The platform digitizes the entire supply chain, facilitating order intake, ingredient conversion, nutrition label creation, recipe costing, and delivery options. Meallogix's user-friendly dashboard provides meal prep business owners with valuable insights into their financial performance, helping them identify profitable menu items and areas for improvement. Additionally, the technology features tools for nutritional analysis, store data analytics, and customer engagement, enabling businesses to enhance their operations and expand their online presence.

MatriSys Bioscience

Venture Round in 2021
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.

YBVR

Seed Round in 2021
YBVR specializes in creating video-centric immersive experiences for the sports industry, leveraging its technology across various platforms, including mobile, web, and extended reality (XR) devices. Since its inception in 2017, YBVR has established a strong reputation in immersive sports, partnering with notable organizations such as Real Madrid, the Australian Open, and Euroleague Basketball. In 2022, YBVR collaborated with Meta to launch Xtadium, a platform dedicated to sports in the Metaverse, featuring content from prominent leagues like the NBA and UFC. The company's offerings enable broadcasting networks and content creators to enhance the quality and engagement of live events, entertainment, and educational experiences through superior video resolution.

New Age Meats

Seed Round in 2021
New Age Meats is a biotechnology company that develops healthy cultivated meat grown from animal cells instead of animal slaughter.

Zigazoo

Seed Round in 2021
Zigazoo is a social media brand that focuses on providing a safe and creative environment for children, specifically targeting Generation Alpha. Launched in 2020, the Zigazoo app allows kids and families to engage with educational prompts through short videos, fostering healthy online relationships and promoting self-expression. The platform has rapidly gained popularity, becoming the largest social network for this demographic and attracting top-tier creator talent, celebrities, and major brands such as the NBA and Netflix. Zigazoo aims to make screen time healthier and more enriching, empowering millions of children to express their authentic selves while enjoying a positive social media experience. The company has received support from notable investors in the tech and entertainment sectors, further solidifying its position in the market.

Amsel Medical

Convertible Note in 2021
Amsel Medical is a medical device company specializing in innovative surgical clamping technology aimed at enhancing surgical and interventional procedures. The company's flagship product, the SCureClamp, utilizes Interdigitation Occlusion Technology (iDOT) to effectively close vessels, including veins and arteries, ensuring secure and reliable occlusion. This device incorporates an anchoring feature that prevents slippage, allowing medical professionals to grasp and occlude vessels of varying sizes, types, and wall thicknesses. Amsel Medical's technology not only facilitates faster healing of blood vessels but also supports minimally invasive delivery methods, making it suitable for both clinical and military applications. The company's advancements in occlusion devices have garnered positive acceptance in initial clinical trials, demonstrating their commitment to improving patient outcomes.

Allotrope Medical

Series A in 2021
Allotrope Medical is a Houston-based medical device company. Allotrope Medical’s first device, the StimSite, is an intuitive hand-held device that assists surgeons in quickly and easily identifying ureters during a surgical procedure.

Strategikon Pharma

Seed Round in 2020
Strategikon Pharma, Inc. specializes in developing software that optimizes the outsourcing processes between sponsors and providers in the pharmaceutical industry. Its flagship product, Clinical Maestro, is a unique platform designed for the comprehensive management of clinical business operations, particularly in planning, outsourcing, and budgeting clinical trials. By facilitating an integrated virtual environment, Clinical Maestro enables biopharmaceutical companies to efficiently manage complex relationships with numerous global service providers who often operate with varying processes and reporting structures. The software replaces traditional, labor-intensive methods—primarily reliant on Excel—leading to significant cost savings and enhanced operational efficiency. Case studies with major pharmaceutical firms highlight the platform's effectiveness, achieving over 80% savings compared to manual processes and over 95% accuracy in predicting clinical study budgets. Founded in 2016 and headquartered in San Rafael, California, Strategikon Pharma also offers consulting services to support new clinical business operations.

ExpressCells

Venture Round in 2020
ExpressCells is a biotechnology company that uses genetic engineering to create custom cell lines for biological research and drug discovery. The company's primary focus is on creating research tools that will speed drug discovery and provide better disease models for basic researchers. ExpressCells was established by Oscar Perez-Leal and Matt Handel in 2018 and is headquartered in Philadelphia, Pennsylvania.

Terecircuits

Venture Round in 2020
Terecircuits develops processes and materials to support microassembly and mass transfer for displays and advanced electronics.

Amplyx Pharmaceuticals

Series A in 2020
Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.

New Age Meats

Seed Round in 2020
New Age Meats is a biotechnology company that develops healthy cultivated meat grown from animal cells instead of animal slaughter.

Abintus Bio

Convertible Note in 2020
Abintus Bio is a preclinical stage gene therapy company that engages in the field of in vivo immune cell reprogramming. The company pursues products that modulate immune cells from within their native environment to enhance patient access and patient outcomes. It focuses on the discovery and development of a portfolio of first-in-class, product candidates that are designed to directly reprogram immune cells from within their native environment using proprietary vectors and related technologies.

Maxwell Biomedical

Convertible Note in 2020
Maxwell Biomedical, Inc. is a medical device company based in Solana Beach, California, that specializes in developing innovative solutions for atrial fibrillation (AF). Established in 2018, the company is focused on creating a unique device designed to deliver shock-free termination of AF episodes. This device offers real-time, pain-free left atrial pacing to maintain normal sinus rhythm in patients affected by AF. It encompasses a fully integrated care system that includes spatial resynchronization therapy and advanced patient management features. By monitoring and diagnosing AF, the device can detect episodes and perform anti-AF pacing to restore sinus rhythm, ultimately aiming to reduce the frequency and severity of AF events and slow disease progression. Additionally, Maxwell Biomedical integrates cloud-based telehealth capabilities to enhance remote patient management.

Somabar

Convertible Note in 2020
Somabar, Inc. designs and manufactures a robotic bartending appliance aimed at the home kitchen market, capable of mixing cocktails and beverages swiftly and accurately. This innovative device features an extensive digital bar menu that allows users to create a variety of cocktails in approximately ten seconds. The technology is equipped with automated cleaning capabilities and is built for durability, with a lifespan rated for 1,500 hours of continuous use, equivalent to producing 500,000 drinks. Somabar serves a diverse clientele, including restaurants, bars, hotels, and various public and private venues. Testing in restaurant environments in Los Angeles has shown that Somabar can increase beverage revenue by an average of 30% while reducing labor costs by about 65%. Originally known as Janglowe Holdings, Inc., the company rebranded to Somabar, Inc. in March 2017 and was incorporated in 2011, with its headquarters in Los Angeles, California.

Fitplan

Convertible Note in 2020
Fitplan is a fitness application that collaborates with renowned fitness icons, athletes, and professional trainers to develop customized training programs and meal plans. The platform provides users with access to exclusive fitness content designed to help individuals maintain their health and fitness goals. By featuring personalized workout schedules and nutritional guidance from top fitness influencers and experts, Fitplan aims to support both casual users and dedicated fitness enthusiasts in their pursuit of improved well-being. Through its user-friendly application, Fitplan emphasizes tailored fitness solutions to enhance the overall fitness experience.

GroupSolver

Venture Round in 2020
GroupSolver, Inc. is a market research technology company that offers an intelligent platform for real-time qualitative and quantitative insights. The platform enables businesses, decision makers, and researchers to gather and analyze natural language feedback from consumers, moving beyond traditional multiple-choice responses. Key solutions include GroupSolver, which organizes and quantifies open-ended answers; IdeaCluster, which identifies correlations between responses; IntelliSegment, for understanding differences in answers across specific respondent segments; and IdeaCloud, which prioritizes the most supported answers. Additionally, the Consensus Solution highlights positively correlated responses. The company supports various research needs, including concept testing, ad testing, pricing analysis, brand evaluation, and customer experience. Founded in 2014, GroupSolver is headquartered in San Diego, California, with additional offices in Provo, Utah, and Košice, Slovakia.

PetDx

Series A in 2020
PetDx is a San Diego-based molecular diagnostics company focused on enhancing pet health through advanced genomic technologies. The company's primary offering, OncoK9, is a pioneering multi-cancer early detection test that allows veterinarians to identify cancer in dogs through a simple blood draw. This first-in-class liquid biopsy utilizes next-generation sequencing and proprietary bioinformatics to analyze genetic material, facilitating early detection, characterization, and management of cancer in pets. By providing a non-invasive testing option, PetDx supports veterinarians in delivering improved care and outcomes for canine patients.

Ready, Set, Food!

Convertible Note in 2020
Ready, Set, Food! is a California-based company founded in 2017 that specializes in manufacturing and selling infant food products designed to help reduce the risk of allergies to peanuts, eggs, and milk. The company offers a gentle, daily system that can decrease the likelihood of developing these common allergies by up to 80%. Its products are available for purchase online, making it accessible for parents seeking to introduce allergenic foods into their infants' diets safely.

Labviva

Venture Round in 2020
Labviva, Inc. operates a digital marketplace tailored for the life sciences sector, connecting researchers with suppliers of reagents, chemicals, and laboratory equipment. Founded in 2015 and based in Somerville, Massachusetts, the platform offers a wide range of products, including antibodies, biological kits, buffers, chromatography supplies, and various laboratory devices. Labviva enhances the user experience by leveraging scientific context to streamline the procurement process, making it easier for suppliers to manage product content. Its Inventory Management System provides real-time inventory tracking and AI-driven purchase automation, thus improving operational efficiency and compliance. By offering insights into lab purchasing trends and supply chain health, Labviva enables clients to maintain contract pricing with preferred vendors and establish direct partnerships without the complexity of managing multiple catalogs.

Noria Water Technologies

Convertible Note in 2020
Noria Water Technologies specializes in optimizing membrane-based water treatment and desalination processes through its innovative monitoring solutions. The company has developed a patented hardware and software system that utilizes machine learning and artificial intelligence to provide real-time imaging of membranes within high-pressure vessels. This technology allows for precise detection and forecasting of membrane fouling and scaling, as well as the identification of foulant types. Noria's integrated hardware and software-as-a-service system enhances plant performance, enabling significant operational cost savings. The primary market for Noria includes municipal and industrial facilities that utilize membrane technologies for various applications such as seawater desalination, freshwater purification, and wastewater treatment. Industries served include oil and gas, electric power generation, and mining. With growing global demands for freshwater, Noria aims to make water treatment processes more efficient, affordable, and sustainable. Founded in 2013 and headquartered in Los Angeles, California, Noria is committed to advancing water treatment technologies to meet future challenges.

Strategikon Pharma

Venture Round in 2020
Strategikon Pharma, Inc. specializes in developing software that optimizes the outsourcing processes between sponsors and providers in the pharmaceutical industry. Its flagship product, Clinical Maestro, is a unique platform designed for the comprehensive management of clinical business operations, particularly in planning, outsourcing, and budgeting clinical trials. By facilitating an integrated virtual environment, Clinical Maestro enables biopharmaceutical companies to efficiently manage complex relationships with numerous global service providers who often operate with varying processes and reporting structures. The software replaces traditional, labor-intensive methods—primarily reliant on Excel—leading to significant cost savings and enhanced operational efficiency. Case studies with major pharmaceutical firms highlight the platform's effectiveness, achieving over 80% savings compared to manual processes and over 95% accuracy in predicting clinical study budgets. Founded in 2016 and headquartered in San Rafael, California, Strategikon Pharma also offers consulting services to support new clinical business operations.

Blue

Convertible Note in 2020
Blue Social gamifies meeting others in real life using OpenAI, Self-Sovereign NFT Identities and proximity-based Bluetooth. Users earn rewards and income for in-person interactions, while businesses can advertise using proximity marketing - a $65B industry.

Terecircuits

Convertible Note in 2020
Terecircuits develops processes and materials to support microassembly and mass transfer for displays and advanced electronics.

Gali Health

Seed Round in 2020
At Gali Health, we are on a mission to make sure nobody ever feels isolated, lost or powerless in the face of existing or potential disease. We are working to advance consumer-powered healthcare by crowdsourcing personal health data and medically-validated insights, applying AI to process them and providing highly personalized informational support on the medical, lifestyle and psychological aspects of living with chronic disease. Our mobile personal health assistant named Gali relies on collective intelligence to help people with chronic conditions proactively manage their health.

GroGuru

Convertible Note in 2020
GroGuru Inc. is a technology company based in La Jolla, California, that specializes in smart irrigation solutions for agriculture. Founded in 2014, GroGuru provides software as a service focused on irrigation monitoring and management. The company's platform utilizes an Internet of Things (IoT) sensor network to deliver precise measurements of soil moisture, salinity, and temperature. This data-driven system enables farmers to optimize water usage and improve crop yields by offering real-time insights and recommendations for irrigation scheduling and water management. GroGuru aims to promote sustainable farming practices while enhancing agricultural productivity and conserving water resources, ultimately helping farmers reduce input costs associated with water, energy, and fertilizer.

NovaSignal

Venture Round in 2020
NovaSignal Corporation is a medical device company that specializes in the research, development, and manufacturing of advanced diagnostic systems for brain health management. Founded in 2013 and based in Los Angeles, California, with a location in Bengaluru, India, NovaSignal's key products include the Lucid robotic system and the Lucid M1 system. These innovative devices utilize a combination of non-invasive ultrasound, robotics, and artificial intelligence to facilitate the early detection of conditions such as stroke, trauma, and dementia by analyzing real-time cerebral blood flow. The company's technology enables clinicians to accurately assess brain health by automatically adjusting the orientation and position of the device to capture critical data. Formerly known as Neural Analytics, Inc., the company rebranded to NovaSignal Corporation in July 2020.

Nevados

Convertible Note in 2020
Nevados Engineering specializes in designing and manufacturing solar ground installations, specifically focusing on single-axis solar trackers that simplify the installation process for solar power plants. These trackers are engineered to function effectively on various terrains without requiring extensive grading, thus reducing installation complexity and costs. The company aims to enhance power generation while offering services that enable solar developers to explore more site options and improve profitability. With significant support from the Department of Energy, Nevados is positioned to supply its innovative systems to solar developers, contributing to more efficient and cost-effective solar energy solutions.

Habitu8

Convertible Note in 2020
Habitu8, Inc. offers security awareness training programs designed to educate employees about cybersecurity threats and promote safer behaviors within organizations. Founded in 2017 and based in Los Angeles, the company provides a range of services that cover critical topics such as GDPR compliance, ransomware, phishing, social engineering, and mobile device security, among others. Its platform features engaging videos and custom training programs, aimed at empowering workers to recognize and mitigate risks associated with their actions. By focusing on practical scenarios and effective messaging, Habitu8 seeks to foster a culture of security awareness that benefits both individual employees and their organizations.

Whistle

Venture Round in 2020
Whistle is a guest messaging platform focused on enhancing communication between hotels and their guests, facilitating engagement throughout the entire stay. By leveraging popular mobile messaging apps and SMS, Whistle allows businesses to interact with customers in a familiar environment, reducing the need for additional applications. The platform aggregates customer communications into user-friendly web and mobile admin panels, enabling real-time responses and efficient management of inquiries. It offers features such as chatbots, ticket creation and tracking, as well as analytics and insights, which help hotels address guest needs proactively and improve service quality. By providing an intermediary outlet for feedback, Whistle helps mitigate negative reviews and fosters a connection between customers and staff. The platform also enables businesses to gather customer satisfaction data through direct messaging, bypassing traditional surveys that often yield low engagement. Ultimately, Whistle aims to create a seamless digital experience for guests while driving operational efficiency and increasing revenue for hotels.

Upcycle and Company

Venture Round in 2020
Upcycle and Company, LLC, based in Fresno, California, specializes in the production and sale of natural fertilizers derived from organic waste. Established in 2015, the company offers a unique product known as Upcycle Active Fertilizer™, which enhances soil health and fosters a balanced ecosystem by providing essential components such as carbon, organic matter, and slow-release nutrients. This formulation addresses the significant decline in soil quality over the past century, which has seen a 70% reduction in carbon and organic matter. Upcycle and Company's fertilizers are utilized by landscapers and farmers to rebuild soil health, improve plant growth, and reduce water requirements by 15%. The products are distributed through retail partners and online platforms, serving a diverse clientele interested in sustainable agricultural practices.

Insight Medical

Convertible Note in 2020
Insight Medical is a developer of a medical device used for orthopedic surgical procedures. It is focusing first on applications in computer-assisted surgery in orthopedic procedures including joint replacement, ACL reconstruction, and spinal fusion through its proprietary Augmented Reality Visualization and Information System. Its system has tracking and visualization capabilities that allow precise and efficient execution of preoperative surgical plans in the position of instruments and implants relative are calculated and displayed numerically or graphically that enable physicians to streamline the surgery, improve outcomes, and reduce risk based on patient-specific information. Insight Medical was established in 2016 and is based in Laguna Hills, California.

Razberi Technologies

Venture Round in 2020
Razberi Technologies, Inc. specializes in developing and manufacturing network video solutions tailored for professional video surveillance and security applications. The company offers a comprehensive range of products, including plug-and-play network recorders, IP cameras, and installation tools, with its flagship product being the Razberi ServerSwitch, which integrates the functionalities of a network video recorder and an Ethernet Smart Switch. Additionally, Razberi provides innovative cybersecurity solutions, such as Razberi CameraDefense, which automates camera hardening to protect surveillance systems from cyber threats, and Razberi Monitor, a health monitoring software that allows enterprise network administrators to oversee network performance and manage systems remotely. The company's products and services cater to various sectors, including energy, finance, government, education, and transportation, and are distributed through authorized channels in multiple regions worldwide. Razberi Technologies, founded in 2011, is headquartered in Farmers Branch, Texas, and operates as a subsidiary of ACRE, LLC.

Casana

Seed Round in 2020
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.

Blackdot

Convertible Note in 2020
Blackdot, Inc., founded in 2018 and based in Austin, Texas, specializes in body tattooing services. The company aims to reinvent the tattooing experience by integrating innovative technologies that enhance the process for both artists and clients. By focusing on a curated and luxury approach to tattooing, Blackdot seeks to create a more comfortable and personalized experience while enabling individuals to express their stories through body art. The company is dedicated to advancing the art of tattooing, supporting artists in showcasing their work, and ensuring that clients have a positive and engaging experience.

iDENTICAL

Convertible Note in 2020
iDENTICAL, Inc. specializes in creating personalized dental implants tailored to the unique structure of each patient’s tooth. Founded in 2018 and headquartered in Mountain View, California, the company focuses on making tooth replacement more accessible and affordable through its innovative drill-free, non-invasive implants. Utilizing advanced 3D scanning and printing technology, iDENTICAL enables dentists to provide customized dental implants efficiently and safely. This approach revolutionizes the traditional tooth replacement process, allowing family dentists to offer a streamlined treatment option for individuals experiencing tooth loss.

Eyedaptic

Convertible Note in 2020
Eyedaptic, Inc. is a manufacturer of augmented reality glasses equipped with visual aid software specifically designed for individuals with macular degeneration and other retinal diseases. The company's primary product, Eyedaptic EYE2, optimizes the user’s field of vision, effectively addressing central vision disorders such as age-related macular degeneration (AMD). Developed in collaboration with leading ophthalmology retinal specialists and low vision optometrists, the device, known as AdaptiVu, is a comfortable, non-invasive, battery-powered optical aid that simulates natural vision. Eyedaptic was established in 2016 and is headquartered in Laguna Hills, California.

YouMail

Venture Round in 2020
YouMail Inc. is a company that specializes in developing a cloud-based security application for mobile phones, primarily focused on enhancing telecommunications services. Its application effectively blocks robocalls and phishing messages, thereby safeguarding users from spam, identity theft, and corporate fraud. The platform offers features such as visual voicemail, personalized greetings, and voicemail management, allowing users to read, organize, share, reply, and save their messages seamlessly. YouMail's services are available in multiple countries, including the United States, Canada, Australia, and various European nations. The company employs a freemium model, with its flagship Visual Voicemail Plus application being available for free and compatible across several platforms, including Android and iPhone. Founded in 2007 and headquartered in Irvine, California, YouMail has gained significant traction, with millions of downloads and registered users, all acquired organically.

Turn Technologies

Convertible Note in 2020
Turn Technologies, Inc. is a Chicago-based company that specializes in developing an AI-powered workforce-as-a-service platform aimed at managing workers. Founded in 2016, the company focuses on hiring hourly, shift-based, and contracted workers, utilizing advanced screening and AI sourcing techniques. Its platform is designed for speed and accuracy, offering features such as mobile-friendly services, seamless API and HR integration, flexibility in planning, comprehensive candidate profiles, and built-in support tools. This comprehensive approach allows companies to efficiently source, screen, and retain workers, enhancing their workforce management capabilities.

Advekit

Venture Round in 2020
Advekit is a healthcare platform used to make the process of finding a mental health support therapist easy, empowering, and encouraging. The platform helps patients find the right therapist and use their insurance to pay for therapy. It improves access to quality treatment and helps individuals better utilize their mental health benefits and offers a sliding-scale fee structure, which is a variable rate based on a person's ability to pay for treatment, thus helping users in simplifying the process of finding therapists based on their needs, availability, and insurance.

Hawthorne Effect

Convertible Note in 2020
Hawthorne Effect's mission is to make clinical trials accessible to everyone, everywhere. The company's proactive Visit Management System honors the relationship between sponsors and their investigators and promotes the use of shared technology to ensure protocol compliance and eliminate missing data. By enabling research teams to not only track all of their patients and thousands of data points but deploy specially trained healthcare providers (“HEROs”) to conduct visits anywhere, anytime, Hawthorne Effect ensures that no patients are “lost to follow-up.

Aligned Carbon

Venture Round in 2020
Aligned Carbon Inc. is a manufacturer of carbon nanotubes (CNTs) specifically designed for the integrated circuit industry. Founded in 2018 and based in Santa Clara, California, the company is the first to offer semiconductor-pure, aligned CNTs on industry-standard wafers at a manufacturing scale. These CNTs are aligned in arrays that cover full semiconductor substrates and can be purified to serve either semiconducting or metallic functions. Aligned Carbon's technology allows semiconductor foundries to move beyond traditional silicon, leading to significant enhancements in processing speed, energy efficiency, and capabilities in signal processing and sensing. The company's CNTs are also utilized as transistor materials in displays and thin film transistors, providing clients with innovative solutions for advanced computing applications.

Seatrec

Seed Round in 2020
Seatrec is a climatetech startup focused on generating clean and sustainable energy from temperature differences in ocean waters. Founded in 2012 by Dr. Yi Chao, the company has leveraged technology developed at the NASA Jet Propulsion Laboratory to create patented thermal engine systems. These systems provide renewable electricity to power oceanographic research equipment such as drones, floats, and gliders. By utilizing Seatrec’s technology, researchers can significantly extend the operational life of their equipment, reduce costs, and enhance data collection capabilities, all while producing zero emissions and waste. The applications of this technology span various fields, including ocean data capture, seafloor mapping, offshore aquaculture, Arctic research, meteorology, and climate change mitigation.

DTx Pharma

Series A in 2020
DTx Pharma, LLC is a biotechnology company focused on developing and commercializing fatty acid-conjugated peptide therapeutics for patients with rare and chronic diseases. The company specializes in RNA-based therapeutics, utilizing a delivery technology platform that enhances the distribution of nucleic acid drugs to various tissues and organ systems beyond the liver. This innovative approach addresses limitations associated with previous-generation RNA delivery methods, such as poor pharmacokinetics and inadequate cellular uptake. DTx Pharma's products target conditions including retinitis pigmentosa, Duchenne muscular dystrophy, and central nervous system disorders. Founded in 2017 and based in San Diego, California, DTx Pharma aims to provide personalized treatment options across multiple therapeutic areas.

Esper

Private Equity Round in 2019
Esper, founded in 2018 by Yadhu Gopalan and Shiv Sundar, specializes in device and application management solutions tailored for Android-based dedicated devices. The company's platform equips device manufacturers and chipset vendors with the necessary tools to create a streamlined Android experience, specifically designed for enterprise environments. Esper's software allows businesses to manage their device fleets comprehensively, including capabilities for real-time debugging of applications on remote devices. This functionality enhances the ability to securely deploy, monitor, and optimize applications across various edge devices in the field, fostering innovation in Android development and operations.

Trials.ai

Convertible Note in 2019
The Trials.ai Smart Protocol system leverages artificial intelligence to efficiently navigate research teams in designing clinical trials that enable pharma, biotech and device companies to get treatments to patients faster. Trial sponsors spend $65B every year on clinical trials and 45% of those trials fail because they are poorly designed. These failures equate to billions of dollars in lost opportunity for trial sponsors every year - but more importantly, patients don't have time to wait for us to get it right. In the digital age, humans cannot physically read and digest every bit of information relevant to a given decision. In addition, almost every organization has what is called 'dark' or 'siloed' data – valuable data that is not being used, or that organizations don’t know they have at their disposal. It is estimated that as much as 90% of the data within a given organization is dark or siloed. As a result, pharmaceutical companies are making important decisions with incomplete information. ENTER TRIALS.AI - we are on a mission to get effective treatments to patients faster by using artificial intelligence to optimize clinical trial designs for speed and success. Unlike the current service models out there, we use smart technology to harness vast amounts of data that no human can process – then offer unique insights across therapeutic areas to trial sponsors. Using our codified clinical trials database, we are able to unlock information, derive insights and make recommendations to trial sponsors on how to best design & optimize their trial protocols. Based in San Diego, California, Trials.ai launched by Kim Walpole in 2016.

Casana

Angel Round in 2019
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.

Kangarootime

Series A in 2019
Kangarootime, Inc. is a company that offers a cloud-based childcare management solution aimed at connecting parents with childcare professionals. Founded in 2015 and headquartered in Buffalo, New York, Kangarootime provides a comprehensive platform that includes features such as revenue cycle management, mobile accessibility, enrollment, attendance tracking, messaging, picture sharing, employee management, and reporting. The platform is designed to automate processes like check-in and check-out, facilitating better communication and compliance for childcare centers. By streamlining operations and enhancing connectivity with families, Kangarootime empowers childcare professionals to digitize their businesses and effectively manage their classrooms.

Recess

Seed Round in 2019
Recess operates as an experiential partnership marketing platform that facilitates connections between brands and consumers through event and venue partnerships across the United States. The company provides an online platform that allows brands to discover, book, and execute marketing activations at various events, particularly targeting college students through partnerships with universities. Founded in 2013 and headquartered in Marina del Rey, California, Recess offers a comprehensive solution for advertisers, enabling them to engage and acquire new customers efficiently. The platform streamlines the process of executing experiential partnerships, allowing users to manage logistics, contracts, and payments while measuring the return on investment. Additionally, Recess organizes music and ideas festivals that foster collaboration among entrepreneurs, startups, and artists, further enhancing its role in the event marketing landscape.

Capillary Biomedical

Private Equity Round in 2019
Capillary Biomedical, Inc. is a medical device company founded in 2014 and located in Irvine, California. The company focuses on developing innovative technologies for diabetes management, particularly in simplifying glucose monitoring and insulin delivery. As a spin-out from the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University, Capillary Biomedical is dedicated to reducing the burden of diabetes on patients and the healthcare system. Its flagship product features a kink-proof, flexible, multiport cannula designed for reliable and comfortable insulin delivery, with an emphasis on a straightforward one-handed insertion process. This user-friendly design aims to assist diabetes patients in achieving better blood glucose control.

Visgenx

Convertible Note in 2019
Visgenx, Inc. is a biotechnology company based in San Diego, California, focused on developing gene therapies for retinal diseases, particularly macular degeneration and geographic atrophy. Founded in 2018, the company specializes in gene reactivation through hypomethylation therapy, targeting the regulation of the ELOVL2 gene. This gene is believed to play a crucial role in the aging of cells essential for vision. By increasing the expression of ELOVL2, Visgenx aims to protect against the loss of sight caused by retinal disorders, offering potential therapeutic solutions for individuals affected by these conditions.

MatriSys Bioscience

Venture Round in 2019
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.

GroLens

Convertible Note in 2019
GroLens is a developer of cultivation software designed to support cannabis growers in producing high-quality products consistently. The company's platform provides data-driven insights that help optimize growing practices, identify operational efficiencies, and ensure compliance with regulatory requirements. By managing plants throughout their entire lifecycle, GroLens streamlines the reporting process for compliance and simplifies inventory management. This comprehensive approach enables cannabis producers to effectively navigate the complexities of the industry while enhancing their overall operational capabilities.

Healionics

Convertible Note in 2019
Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.

BlueNalu

Series A in 2019
BlueNalu, Inc. is a cellular aquaculture company based in San Diego, California, founded in 2017. It specializes in the production and marketing of cell-based seafood products, cultivating fish tissue from cells to meet the growing global demand for seafood while promoting sustainability. By utilizing innovative techniques, BlueNalu produces healthy, safe, and tasty seafood dishes that are free from plastics, pathogens, toxins, and other contaminants. The company aims to support ocean diversity and sustainability, providing consumers and restaurants with trusted seafood options that align with ethical and environmental standards.

Connected Signals

Private Equity Round in 2019
Connected Signals, Inc. is a company based in Eugene, Oregon, that specializes in providing a cloud-based system connecting vehicles to traffic signals. This technology prioritizes various types of vehicles, including buses, emergency services, and pedestrians, to enhance traffic flow and reduce trip times by optimizing traffic light changes. The company has developed Transit Signal Priority (TSP) that leverages existing hardware in buses along fixed routes. Its applications, such as EnLighten, offer real-time predictions of traffic signal states, enhancing driving safety and efficiency without distracting drivers. EnLighten informs drivers about the duration of red lights and provides alerts as lights change. Additionally, Connected Signals partners with municipalities to gather and standardize real-time traffic signal data, ensuring compatibility with diverse signal infrastructures without necessitating expensive upgrades. Founded in 2013, Connected Signals aims to improve urban mobility while focusing on safety and reducing environmental impact.

Cloudkeyz

Convertible Note in 2019
CloudKeyz, Inc. is a developer of keyless entry systems based in Encino, California, founded in 2014. The company specializes in cloud-secured access solutions for multi-tenant commercial and residential buildings, replacing traditional access cards and keys. Its technology enables users to gain entry to properties through a cellular-based mobile app and touchscreen interface, providing real-time mobile access control. Property managers can efficiently manage access rights via a web-based administration tool, enhancing security and tenant retention while mitigating liability risks. Overall, CloudKeyz’s innovative approach aims to simplify access for tenants and guests while improving operational efficiency for property managers.

EV Connect

Private Equity Round in 2019
EV Connect, Inc. specializes in electric vehicle charging solutions for various sectors, including commercial, enterprise, hospitality, universities, and government facilities, primarily in California and New York. Founded in 2009 and headquartered in El Segundo, California, the company operates a cloud-based platform that facilitates the management of charging stations and enhances the experience for drivers. This platform supports charge station-agnostic command and control, integrates with enterprise and energy systems through an open API, and provides robust driver communications and support. EV Connect aims to streamline the setup and optimization of charging services, offering premium customer support from installation to user experience. The company has a diverse clientele that includes notable organizations such as Verizon, Marriott, and the New York Power Authority, reflecting its commitment to promoting electricity as a sustainable transportation fuel.

Pasturebird

Private Equity Round in 2019
Pasturebird, based in Murrieta, California, specializes in the production of pastured poultry, utilizing a sustainable and natural farming approach. The company raises its poultry in open environments that provide fresh air and sunlight, allowing the birds to roam freely and forage. This method not only enhances the quality of the poultry but also supports environmental health. Over the past five years, Pasturebird has established a reputation for delivering high-quality poultry products and has built partnerships with notable clients, including the LA Lakers, LA Dodgers, and various restaurants, grocery stores, and meal prep services across California and Las Vegas.

Phytonix

Venture Round in 2019
Phytonix Corporation is an industrial biotechnology company producing sustainable chemicals directly from carbon dioxide. The company’s patented process employs cyanobacteria, and it is a professional in bio-safe, direct solar chemicals and fuel production utilizing carbon dioxide as the sole feedstock and energy from the sun. Phytonix Corporation and its partners utilize a collaborative and distributed business model based upon circular economy principles, to produce a variety of renewable chemicals and biofuel from carbon dioxide, sunlight, and water via patented photobiological and genomics technology. It also produces biobutanol and biopentanol, industrial chemicals, and potential fuels to replace gasoline. Phytonix Corporation’s first product in its pipeline, n-butanol, can be used for a broad array of fuels and chemicals, including jet fuels, bio-based plastics, and synthetic rubber. Its n-butanol production process is a replacement for the fossil-based, carbon-intensive process currently used by the world’s largest chemical companies. The company seeks to eliminate the need for biomass, such as food or other crops, in both biochemical and biofuel production. Phytonix Corporation has developed engineered cyanobacterial species that secrete n-butanol in a significantly carbon-negative, photosynthetic process. The company estimates that the production cost of its biobutanol will be 1.35 U.S. dollars per gallon. It was founded in 2009 by Bruce Dannenberg and is headquartered in Asheville, North Carolina.

Aquacycl

Seed Round in 2019
Aquacycl LLC is a wastewater treatment company based in San Diego, California, specializing in innovative equipment for onsite wastewater treatment plants. Founded in 2016, the company utilizes bioelectrochemical treatment technology (BETT) reactors to efficiently eliminate primary sludge and recover energy as direct electricity, avoiding methane production. Aquacycl's packaged treatment plants feature a rapid four-hour treatment time and can be scaled for various applications, including industrial, agricultural, military, and residential settings, accommodating communities of up to 2,500 individuals. The company's operations are designed to minimize energy consumption, offering potential operational cost savings for its clients. Aquacycl has established laboratories in Sorrento Valley, California, and maintains pilot installations in Escondido, California, and Tijuana, Mexico, while actively seeking strategic partners and investors to further its mission.

Snapwire

Venture Round in 2019
Snapwire is a marketplace that connects brands with talented creators who produce custom visual content. By posting a creative brief, businesses can receive submissions from skilled creators worldwide, ensuring that the content aligns with their vision. This platform facilitates collaboration between brands and creators, streamlining the visual content production process. Snapwire's mission is to empower individuals passionate about creativity, allowing them to thrive while delivering unique content to clients. The marketplace features a network of vetted creators, enabling brands to efficiently scale their visual production to meet contemporary demands.

Mobilize Solutions

Convertible Note in 2019
Mobilize Solutions, Inc. is a company based in Irvine, California, that specializes in customer engagement through a unique platform designed for social media interaction. The platform enables businesses to create and share branded content, particularly user-generated advertisements, which serve as an effective alternative to traditional paid advertising. Mobilize Solutions has partnered with notable clients, including Toyota USA and Salesforce, to enhance brand visibility and customer engagement. Their scalable and configurable technology allows wireless providers and app publishers to easily integrate the platform, facilitating promotional activities that encourage users to share their experiences with friends on social media. This innovative approach positions Mobilize Solutions as a potential leader in a rapidly growing market focused on user-generated content.

Habitu8

Convertible Note in 2019
Habitu8, Inc. offers security awareness training programs designed to educate employees about cybersecurity threats and promote safer behaviors within organizations. Founded in 2017 and based in Los Angeles, the company provides a range of services that cover critical topics such as GDPR compliance, ransomware, phishing, social engineering, and mobile device security, among others. Its platform features engaging videos and custom training programs, aimed at empowering workers to recognize and mitigate risks associated with their actions. By focusing on practical scenarios and effective messaging, Habitu8 seeks to foster a culture of security awareness that benefits both individual employees and their organizations.

Pathware

Private Equity Round in 2019
Pathware Inc. specializes in developing automated point-of-care biopsy assessment systems aimed at enhancing the diagnostic capabilities of clinicians and pathologists. Its flagship product, Bioptic, allows for the rapid diagnosis of pathogens, while its sample management platform streamlines the pathology workflow by minimizing repetitive tasks. The company’s digital pathology platform integrates advanced hardware and software tools, facilitating immediate analysis of tissue samples at the point of care, thereby reducing the need to send samples to central laboratories. This innovation significantly shortens turnaround times and improves patient care through AI-powered image analysis and telepathology capabilities. Founded in 2017 and headquartered in Ann Arbor, Michigan, with an additional location in Seattle, Washington, Pathware is dedicated to improving healthcare by leveraging computational microscopy and artificial intelligence for more accurate and timely disease diagnosis and treatment.

Llama

Private Equity Round in 2019
Containerizing the last-mile of logistics and delivery.

Mosabi

Pre Seed Round in 2019
Mosabi is a platform designed to provide business and life skills to underserved citizens in emerging markets, focusing on financial literacy and management. Founded in 2019 and headquartered in Wilmington, Delaware, the platform integrates fintech and edtech to deliver essential skills and services. It employs gamified assessments, surveys, financial health checks, and local language chatbots to enhance user engagement and measure learning outcomes. By utilizing data analytics, Mosabi aims to promote financial inclusion, empowering users to make better decisions related to their businesses and personal finances.

Seatrec

Convertible Note in 2019
Seatrec is a climatetech startup focused on generating clean and sustainable energy from temperature differences in ocean waters. Founded in 2012 by Dr. Yi Chao, the company has leveraged technology developed at the NASA Jet Propulsion Laboratory to create patented thermal engine systems. These systems provide renewable electricity to power oceanographic research equipment such as drones, floats, and gliders. By utilizing Seatrec’s technology, researchers can significantly extend the operational life of their equipment, reduce costs, and enhance data collection capabilities, all while producing zero emissions and waste. The applications of this technology span various fields, including ocean data capture, seafloor mapping, offshore aquaculture, Arctic research, meteorology, and climate change mitigation.

Grolltex

Convertible Note in 2019
Grolltex is an advanced materials and biosensor company specializing in the mass production of high-quality, single atomic layer graphene through innovative processes. The company utilizes a patented method known as 'metal assisted exfoliation,' which significantly reduces costs associated with producing large area, mono-layer graphene needed for various applications in electronics manufacturing. This technology addresses the common challenges of transferring CVD generated graphene by efficiently removing it from copper substrates without damaging them, allowing for the copper to be reused in production. Grolltex's graphene can be utilized in a wide range of products, including solar cells, sensors, fuel cells, and ultra-thin flexible displays, making it suitable for wearables and smartphones. The company’s efforts aim to move graphene from the laboratory into practical applications in life sciences, particularly in genomics and molecular detection.

Industry Jump

Convertible Note in 2019
Industry Jump is a global community of filmmakers providing next gen creators with the resources required to grow their business, learn new skills, and manage their careers.

Turn Technologies

Convertible Note in 2019
Turn Technologies, Inc. is a Chicago-based company that specializes in developing an AI-powered workforce-as-a-service platform aimed at managing workers. Founded in 2016, the company focuses on hiring hourly, shift-based, and contracted workers, utilizing advanced screening and AI sourcing techniques. Its platform is designed for speed and accuracy, offering features such as mobile-friendly services, seamless API and HR integration, flexibility in planning, comprehensive candidate profiles, and built-in support tools. This comprehensive approach allows companies to efficiently source, screen, and retain workers, enhancing their workforce management capabilities.

Elemeno Health

Convertible Note in 2019
Elemeno Health, Inc. is a technology company that specializes in developing a mobile software platform aimed at enhancing patient safety and reducing medical errors in healthcare settings. Founded in 2016 and based in Oakland, California, Elemeno provides a team-based medical information platform that serves as a personal assistant for doctors and nurses. The platform offers frontline healthcare teams access to the latest practices, checklists, and instructional videos, facilitating effective communication and point-of-care training. By transforming complex medical practices into concise, actionable steps, Elemeno helps improve practice consistency and accelerates the adoption of best practices. The platform also incorporates gamification and recognition features to engage staff and create a feedback loop, allowing healthcare leaders to gain valuable insights into caregiver behavior and training needs. Elemeno's cloud-based solution can be deployed without the need for hospital IT resources and is accessible on various devices, making it a versatile tool for healthcare providers.

Buy It Installed

Venture Round in 2019
Buy It Installed, Inc. is a technology company located in Irvine, California, that offers an integrated installation solution connecting retailers, manufacturers, and consumers with skilled service providers for installation and product services. The company's platform is designed for the "do it for me" (DIFM) market, allowing online merchants to seamlessly provide installation services alongside product purchases. This approach aims to enhance consumer satisfaction by increasing conversion rates and reducing cart abandonment, product returns, and warranty claims. Utilizing a proprietary technological architecture, Buy It Installed strives to improve business management, ultimately achieving greater efficiency and scale within the installed-sales industry.

Advekit

Venture Round in 2019
Advekit is a healthcare platform used to make the process of finding a mental health support therapist easy, empowering, and encouraging. The platform helps patients find the right therapist and use their insurance to pay for therapy. It improves access to quality treatment and helps individuals better utilize their mental health benefits and offers a sliding-scale fee structure, which is a variable rate based on a person's ability to pay for treatment, thus helping users in simplifying the process of finding therapists based on their needs, availability, and insurance.

Lennd

Convertible Note in 2019
Lennd is an innovative event management platform designed to transform the event production process, which has traditionally relied on spreadsheets and Google Docs. By collaborating with prominent event organizations worldwide, such as The Enthusiast Network and the Los Angeles Marathon, Lennd aims to streamline operations for its users. The platform facilitates the collection, approval, management, tracking, and reporting of critical data related to people, operations, and resources involved in various events. This enhances communication and transparency within teams, ultimately improving the efficiency and effectiveness of event management.

BRIUS

Convertible Note in 2019
Mechanodontics is a revolutionary method that can be used instead of braces or aligners that moves the teeth independently. Placed behind the teeth so they cannot be seen, this method considerably shortens treatment time, allows for easier cleaning than traditional braces, and is more comfortable than any other behind-the-teeth braces.

Outsite

Convertible Note in 2019
Outsite is a collection of unique work+play accommodations that cater to the growing community of entrepreneurs, business travelers and digital nomads who are looking for alternatives to uninspired hotels and conference halls. Whether you want to surf famous waves, ski mountains, climb walls or just bike around town between working sessions, Outsite offers a place to stay with creative co-working spaces and a growing list of innovative “New Networking” activities, designed to spur meaningful and creative collaborations.

Ceresti Health

Convertible Note in 2019
Ceresti Health provide the Best Possible Care for a Loved One Who Relies on You. Ceresti’s care coaching, education and support program makes it easier to navigate the challenges of being a family caregiver.
Deep Blue Medical Advances, Inc. specializes in manufacturing innovative hernia mesh products aimed at improving surgical outcomes for hernia patients. Founded in 2015 and based in Durham, North Carolina, with an additional office in San Francisco, the company has developed the T-Line® hernia mesh, which features integral suture-like extensions designed to enhance fixation and reduce the risk of hernia recurrence. This novel design addresses a critical failure point in conventional mesh fixation, potentially leading to better patient outcomes and lower clinical costs in the $1.1 billion global hernia device market. Additionally, Deep Blue offers Anchor Clip fixation devices that facilitate faster and more reliable mesh implantation. The company's focus on improving the surgical experience and patient satisfaction positions it as a key player in the soft tissue surgery sector.

New View Surgical

Series A in 2019
New View Surgical, Inc. is a medical device company based in Boston, Massachusetts, that specializes in the development and commercialization of the VisionPort technology. This innovative system consolidates four essential surgical devices—a laparoscope, camera, light source, and access port—into a single, easy-to-use, and disposable unit. The VisionPort system aims to enhance minimally invasive surgical procedures by providing surgeons with complete control over visualization and instrumentation. Founded in 2009, the company is led by a team of experienced professionals dedicated to addressing unmet needs in the medical field, offering potential clinical and economic advantages for operating rooms worldwide.

Atlazo

Seed Round in 2019
Atlazo, Inc. is a company that specializes in the design and development of energy-efficient artificial intelligence semiconductors and software, primarily targeting the healthcare industry. Founded in 2016 and based in San Diego, California, Atlazo focuses on addressing the needs of the hearing aid, hearable, wearable, and ultra-low power health Internet of Things (IoT) markets. The company integrates advanced AI technology with bio-sensing capabilities into a single System-on-Chip (SoC) solution, allowing manufacturers to create innovative healthcare products more quickly and cost-effectively. This approach not only enhances the quality of care but also meets the growing demand for reliable health tracking and audio solutions.

Paradigm Diagnostics

Series B in 2019
Paradigm brings cutting-edge diagnostics and biomarker driven clinical trials to benefit cancer patients.Through Next-Gen Sequencing, and other biomarker analysis, Paradigm is able to provide information about the genomic and proteomic landscape of a patient’s cancer, as well as potential therapies based on the specific characterization of the patient’s tumor; thus, personalizing each patient’s course of treatment.

Actuate Therapeutics

Series B in 2019
Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Fort Worth, Texas, with an additional office in Dublin, Ireland. The company focuses on developing novel therapeutics that target Glycogen Synthase Kinase-3β (GSK-3β) for the treatment of various conditions, including Alzheimer’s disease, bipolar disorder, type II diabetes, inflammatory diseases, and several high-impact cancers such as glioblastoma, ovarian, breast, and pancreatic cancers. Actuate is advancing its lead compound, elraglusib (formerly known as 9-ING-41), which is designed to inhibit GSK-3β and disrupt cancer cell survival and growth. The company has demonstrated promising anti-tumor activity in preclinical models, particularly for difficult-to-treat cancers. Actuate Therapeutics aims to discover, develop, and commercialize new therapeutic agents that address significant unmet medical needs in oncology and neurodegeneration.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.